Role of the 5-HT7 Receptor in the Central Nervous System: from Current Status to Future Perspectives

Overview

Journal Mol Neurobiol

Specialties Molecular Biology
Neurology

Date 2011 Mar 23

PMID 21424680

Citations 50

Authors

Anne Matthys

Guy Haegeman

Kathleen Van Craenenbroeck

Peter Vanhoenacker

Affiliations

Soon will be listed here.

Abstract

Pharmacological and genetic tools targeting the 5-hydroxytryptamine (5-HT)7 receptor in preclinical animal models have implicated this receptor in diverse (patho)physiological processes of the central nervous system (CNS). Some data obtained with 5-HT7 receptor knockout mice, selective antagonists, and, to a lesser extent, agonists, however, are quite contradictory. In this review, we not only discuss in detail the role of the 5-HT7 receptor in the CNS but also propose some hypothetical models, which could explain the observed inconsistencies. These models are based on two novel concepts within the field of G protein-coupled receptors (GPCR), namely biphasic signaling and G protein-independent signaling, which both have been shown to be mediated by GPCR dimerization. This led us to suggest that the 5-HT7 receptor could reside in different dimeric contexts and initiate different signaling pathways, depending on the neuronal circuitry and/or brain region. In conclusion, we highlight GPCR dimerization and G protein-independent signaling as two promising future directions in 5-HT7 receptor research, which ultimately might lead to the development of more efficient dimer- and/or pathway-specific therapeutics.

Citing Articles

Molecular Anatomy of Synaptic and Extrasynaptic Neurotransmission Between Nociceptive Primary Afferents and Spinal Dorsal Horn Neurons.

Antal M Int J Mol Sci. 2025; 26(5).

PMID: 40076973 PMC: 11900602. DOI: 10.3390/ijms26052356.

Alterations of Adult Prefrontal Circuits Induced by Early Postnatal Fluoxetine Treatment Mediated by 5-HT7 Receptors.

De Stasi A, Zorrilla de San Martin J, Soto N, Aguirre A, Olusakin J, Lourenco J J Neurosci. 2025; 45(6).

PMID: 39909574 PMC: 11800747. DOI: 10.1523/JNEUROSCI.2393-23.2024.

The cell adhesion molecule CD44 acts as a modulator of 5-HT7 receptor functions.

Borsdorf S, Zeug A, Wu Y, Mitroshina E, Vedunova M, Gaitonde S Cell Commun Signal. 2024; 22(1):563.

PMID: 39580460 PMC: 11585102. DOI: 10.1186/s12964-024-01931-0.

Can Serotonin 7 Receptors Be a Treatment Target for Noncentral Diseases?.

Bilgin A Eurasian J Med. 2024; 55(1):S49-S54.

PMID: 39128036 PMC: 11075038. DOI: 10.5152/eurasianjmed.2023.23303.

DSP-6745, a novel 5-hydroxytryptamine modulator with rapid antidepressant, anxiolytic, antipsychotic and procognitive effects.

Kitaichi M, Kato T, Oki H, Tatara A, Kawada T, Miyazaki K Psychopharmacology (Berl). 2024; 241(11):2223-2239.

PMID: 38856765 DOI: 10.1007/s00213-024-06629-2.

References

Antle M, Ogilvie M, Pickard G, Mistlberger R . Response of the mouse circadian system to serotonin 1A/2/7 agonists in vivo: surprisingly little. J Biol Rhythms. 2003; 18(2):145-58. DOI: 10.1177/0748730403251805. View

Roberts C, Allen L, Langmead C, Hagan J, Middlemiss D, Price G . The effect of SB-269970, a 5-HT(7) receptor antagonist, on 5-HT release from serotonergic terminals and cell bodies. Br J Pharmacol. 2001; 132(7):1574-80. PMC: 1572709. DOI: 10.1038/sj.bjp.0703979. View

Ballaz S, Akil H, Watson S . The 5-HT7 receptor: role in novel object discrimination and relation to novelty-seeking behavior. Neuroscience. 2007; 149(1):192-202. DOI: 10.1016/j.neuroscience.2007.07.043. View

Villalon C, Centurion D, Terron J, Sanchez-Lopez A . Mediation of 5-HT-induced external carotid vasodilatation in GR 127935-pretreated vagosympathectomized dogs by the putative 5-HT7 receptor. Br J Pharmacol. 1997; 120(7):1319-27. PMC: 1564589. DOI: 10.1038/sj.bjp.0701020. View

Harte S, Kender R, Borszcz G . Activation of 5-HT1A and 5-HT7 receptors in the parafascicular nucleus suppresses the affective reaction of rats to noxious stimulation. Pain. 2005; 113(3):405-415. DOI: 10.1016/j.pain.2004.11.023. View

Rocha-Gonzalez H, Meneses A, Carlton S, Granados-Soto V . Pronociceptive role of peripheral and spinal 5-HT7 receptors in the formalin test. Pain. 2005; 117(1-2):182-92. DOI: 10.1016/j.pain.2005.06.011. View

Gasbarri A, Cifariello A, Pompili A, Meneses A . Effect of 5-HT(7) antagonist SB-269970 in the modulation of working and reference memory in the rat. Behav Brain Res. 2008; 195(1):164-70. DOI: 10.1016/j.bbr.2007.12.020. View

Hedlund P, Danielson P, Thomas E, Slanina K, CARSON M, Sutcliffe J . No hypothermic response to serotonin in 5-HT7 receptor knockout mice. Proc Natl Acad Sci U S A. 2003; 100(3):1375-80. PMC: 298780. DOI: 10.1073/pnas.0337340100. View

Ikeda M, Iwata N, Kitajima T, Suzuki T, Yamanouchi Y, Kinoshita Y . Positive association of the serotonin 5-HT7 receptor gene with schizophrenia in a Japanese population. Neuropsychopharmacology. 2005; 31(4):866-71. DOI: 10.1038/sj.npp.1300901. View

10.

Liu H, Irving H, Coupar I . Expression patterns of 5-HT7 receptor isoforms in the rat digestive tract. Life Sci. 2001; 69(21):2467-75. DOI: 10.1016/s0024-3205(01)01318-2. View

11.

Varnas K, Thomas D, Tupala E, Tiihonen J, Hall H . Distribution of 5-HT7 receptors in the human brain: a preliminary autoradiographic study using [3H]SB-269970. Neurosci Lett. 2004; 367(3):313-6. DOI: 10.1016/j.neulet.2004.06.025. View

12.

Krobert K, Bach T, Syversveen T, Kvingedal A, Levy F . The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution. Naunyn Schmiedebergs Arch Pharmacol. 2001; 363(6):620-32. DOI: 10.1007/s002100000369. View

13.

East S, Burnet P, Kerwin R, Harrison P . An RT-PCR study of 5-HT(6) and 5-HT(7) receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia. Schizophr Res. 2002; 57(1):15-26. DOI: 10.1016/s0920-9964(01)00323-1. View

14.

Wesolowska A, Nikiforuk A, Stachowicz K . Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats. Eur J Pharmacol. 2006; 553(1-3):185-90. DOI: 10.1016/j.ejphar.2006.09.064. View

15.

Malberg J, Eisch A, Nestler E, Duman R . Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci. 2000; 20(24):9104-10. PMC: 6773038. View

16.

Abbas A, Hedlund P, Huang X, Tran T, Meltzer H, Roth B . Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo. Psychopharmacology (Berl). 2009; 205(1):119-28. PMC: 2821721. DOI: 10.1007/s00213-009-1521-8. View

17.

Liu R, Ramani B, Soto D, De Arcangelis V, Xiang Y . Agonist dose-dependent phosphorylation by protein kinase A and G protein-coupled receptor kinase regulates beta2 adrenoceptor coupling to G(i) proteins in cardiomyocytes. J Biol Chem. 2009; 284(47):32279-87. PMC: 2781641. DOI: 10.1074/jbc.M109.021428. View

18.

Gardani M, Biello S . The effects of photic and nonphotic stimuli in the 5-HT7 receptor knockout mouse. Neuroscience. 2007; 152(1):245-53. DOI: 10.1016/j.neuroscience.2007.10.028. View

19.

Hedlund P, Sutcliffe J . The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder. Neurosci Lett. 2007; 414(3):247-51. PMC: 1849956. DOI: 10.1016/j.neulet.2006.12.054. View

20.

Horikawa K, Yokota S, Fuji K, Akiyama M, Moriya T, Okamura H . Nonphotic entrainment by 5-HT1A/7 receptor agonists accompanied by reduced Per1 and Per2 mRNA levels in the suprachiasmatic nuclei. J Neurosci. 2000; 20(15):5867-73. PMC: 6772527. View